Trial Profile
Eplerenone on Top of ACE Inhibition in Chronic Kidney Disease Patients with Hypertension (EPOCH)
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 06 Jun 2022
Price :
$35
*
At a glance
- Drugs Eplerenone (Primary) ; ACE inhibitors; Enalapril
- Indications Hypertension
- Focus Pharmacodynamics
- Acronyms EPOCH
- 17 Jun 2020 Planned End Date changed from 1 Dec 2016 to 31 Dec 2021.
- 17 Jun 2020 Planned primary completion date changed from 1 Dec 2016 to 31 Dec 2020.
- 19 Apr 2013 New source identified and integrated (ClinicalTrials.gov: US National Institutes of Health; NCT01832558).